Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Reexamination Certificate
2007-09-04
2007-09-04
Saucier, Sandra E. (Department: 1657)
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Reexamination Certificate
active
10537301
ABSTRACT:
The present invention relates to a pharmaceutical composition comprising a non-viable cell lysate and at least one antiflocculant and/or antisedimentation agent(s). The pharmaceutical composition of the present invention comprising the cell lysate is in the form of a solution or a suspension or a lyophilisate, in particular, the homogenized cell lysate compositions are in the form of solutions or suspensions or lyophilisates. The present invention further discloses processes for the production and the use of the pharmaceutical composition.
REFERENCES:
patent: 3956519 (1976-05-01), Evans et al.
patent: 4565635 (1986-01-01), Le Du et al.
patent: 5387415 (1995-02-01), Wunderlich et al.
patent: 5804213 (1998-09-01), Rolf
patent: 5866167 (1999-02-01), Van Bossuyt
patent: 6010719 (2000-01-01), Remon et al.
patent: 6046178 (2000-04-01), Silvetti, Sr.
patent: 6126935 (2000-10-01), Van Bossuyt
patent: 6585969 (2003-07-01), Van Bossuyt
patent: 2005/0079147 (2005-04-01), Delaey et al.
patent: 7-267876 (1995-10-01), None
patent: WO95/01782 (1995-01-01), None
patent: 97/41899 (1997-11-01), None
Hodge et al, “Flocculation or Bacteria by Hydrophilic Colloids”, Aug. 29, 1957, vol. 75, pp. 258-264.
Tempio et al, J. Pharm. Sci., Oct. 1980; 69(10):1209-14 (Abstract).
Vanapalji et al, Journal of Agricultural and Food Chemistry 50 (18):5224-5228 Aug. 28, 2002 (Abstract).
Ye et al, Journal of Agricultural and Food Chemistry 52 (17):5491-5498, Aug. 25, 2004 (Abstract).
Zatz et al, International Journal of Pharmaceutics, vol. 9, Issue 4, Oct. 1981, pp. 315-319 (Abstract).
Velez et al, Journal of Agricultural and Food Chemistry 51(1):265-269, Jan. 1, 2003 (Abstract).
Quintana et al, Journal of Texture Studies 33(3):215-236, Sep. 2002 (Abstract).
Hemar et al, Food Hydrocolloids 15(4-6):513-519, Jul.-Nov. 2001 (Abstract).
Singh et al, Current Science 78(7):798-803, Apr. 10, 2000 (Abstract).
Koczo et al, Food Hydrocolloids 12(1):43-53, Jan. 1998 (Abstract).
Zatz et al, International Journal of Pharmaceutics 9(4):315-319, 1981 (Abstract).
Walkenstrom et al “Effects of fluid shear and temperature on whey protein gels, pure or mixed with xanthan”, Food Hydrocolloids 12 (1998) 469-479.
Press Release—“43% relative improvement versus control group in hard-to-heal venous leg ulcers obtained with XCELLentis' LyphoDerm™” Gent (Belgium), Mar. 2, 2004 (printed from URL: innogenetics.com/site/pressview.asp?id=125&lang=E on Feb. 13, 2007).
De Waele Peter
Delaey Bernard
Remon Jean-Paul
Vervaet Chris
CellTran Limited
Nixon and Vanderhye P.C.
Saucier Sandra E.
Singh Satyendra K.
LandOfFree
Pharmaceutical compositions of cell lysate and processes for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions of cell lysate and processes for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of cell lysate and processes for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3740957